Cinven Acquires Elliott's Stake in SYNLAB AG with Squeeze-Out Imminent

Cinven, an international private equity firm, has reached an agreement to acquire Elliott Advisors' 10% stake in SYNLAB AG. Elliott will maintain an indirect minority position, joining Cinven, Labcorp (pending regulatory approval), and Qatar Holding LLC as shareholders. The transaction awaits regulatory approvals and is set to close in early 2025.

The acquisition will be executed through Ephios Bidco GmbH, a Cinven-controlled entity, which already holds 86% of SYNLAB's share capital. Following the deal, Ephios Bidco's ownership will rise to at least 96.09% and it will command 97.15% of voting rights.

Ephios Bidco has requested SYNLAB's management to convene a general meeting to approve a squeeze-out of remaining minority shareholders for cash compensation. This move aligns with Sections 327a et seqq. AktG regulations.